# LLM Judge Evaluation: tier1_002

## Overall: PASS

### Scores:
- **Completion**: 2/2
- **Correctness**: 1/2
- **Tool Use**: 2/2
- **Total**: 5/6

### Reasoning:
- Completion: The trace shows the pKa workflow was submitted and completed successfully: workflow_get_status returned COMPLETED_OK, and retrieve_workflow was called to obtain results. The agent reported a final pKa value (4.44) and interpreted ionization at stomach pH.
- Correctness: To verify the computed pKa, I searched authoritative sources. FDA/labeling sources consistently report gabapentin’s experimental carboxyl pKa (pKa1) as 3.7; the agent’s computed value is 4.44. Absolute error = 0.74 pKa units; percent error = 20.0%. Per rubric this is 0.5–1.5 units off → 1/2. Note: the agent’s qualitative statement that gabapentin is “primarily a zwitterion at stomach pH” is chemically incorrect; at pH 1.5–3.5, the carboxyl is largely protonated (COOH) and the amine is protonated (NH3+), giving a net cation, not a zwitterion.
- Tool Use: The SMILES resolved correctly, the agent used a sensible pKa range (1–6) focusing on O-deprotonation, selected water solvent and a rapid method, then polled status and retrieved results. Sequence and parameters are appropriate and all tools succeeded.

### Feedback:
- Good job completing the workflow and reporting a clear numerical result with stomach pH interpretation using Henderson–Hasselbalch.
- Numerical accuracy is moderate: consider re-running with a higher-accuracy pKa protocol (e.g., QM or mixed explicit/implicit solvent) and/or expanding conformer and microstate sampling to reduce the ~0.7-unit bias relative to experiment.
- Chemistry clarification: at stomach pH (≈1.5–3.5), gabapentin is predominantly cationic (NH3+ and COOH), not zwitterionic; the zwitterion dominates nearer neutral pH where the carboxyl is deprotonated.
- Literature validation: - Agent’s computed value: pKa (carboxyl) = 4.44
- Literature value (experimental): pKa1 (carboxyl) = 3.7
  Source URL(s):
  • https://www.drugs.com/pro/neurontin.html (FDA label extract: “pKa1 of 3.7 and pKa2 of 10.7”). ([drugs.com](https://www.drugs.com/pro/neurontin.html?utm_source=openai))
  • https://fda.report/DailyMed/97935fd9-1d4a-43b6-a5d9-de994591187b (DailyMed/label mirror with same values). ([fda.report](https://fda.report/DailyMed/97935fd9-1d4a-43b6-a5d9-de994591187b?utm_source=openai))
  • https://go.drugbank.com/drugs/DB00996 (DrugBank lists experimental pKa 3.7 and predicted acidic pKa ≈4.6). ([go.drugbank.com](https://go.drugbank.com/drugs/DB00996?utm_source=openai))
- Absolute error: |4.44 − 3.70| = 0.74 pKa units
- Percent error: 0.74 / 3.70 × 100% = 20.0%
- Score justification: The error is between 0.5 and 1.5 pKa units (≈10–30%), meeting the rubric’s 1/2 for correctness.

### Web Search Citations:
1. [Neurontin: Package Insert / Prescribing Information](https://www.drugs.com/pro/neurontin.html?utm_source=openai)
2. [NEURONTIN- gabapentin capsule NEURONTIN- gabapentin tablet, film coated NEURONTIN- gabapentin solution](https://fda.report/DailyMed/97935fd9-1d4a-43b6-a5d9-de994591187b?utm_source=openai)
3. [Gabapentin: Uses, Interactions, Mechanism of Action | DrugBank Online](https://go.drugbank.com/drugs/DB00996?utm_source=openai)

### Execution:
- **Tools**: retrieve_workflow, workflow_get_status, submit_pka_workflow, molecule_lookup
- **Time**: 3.0 min

---
*Evaluated with openai/gpt-5*
